Koh Ye Xin, Zhao Yun, Tan Ivan En-Howe, Tan Hwee Leong, Chua Darren Weiquan, Tan Ek Khoon, Teo Jin Yao, Ang Kwok Ann, Au Marianne Kit Har, Goh Brian Kim Poh
From the Department of Hepatopancreatobiliary and Transplant Surgery, Singapore General Hospital and National Cancer Centre Singapore, Singapore (Koh, HL Tan, Chua, EK Tan, JY Teo, Goh).
Duke-National University of Singapore Medical School, Singapore (Koh, HL Tan, Chua, EK Tan, JY Teo, Goh).
J Am Coll Surg. 2025 Aug 1;241(2):203-219. doi: 10.1097/XCS.0000000000001250. Epub 2025 Jul 16.
This study compared the clinical and economic outcomes of laparoscopic (LLR) and open liver resection (OLR) for all hepatectomies, including minor and major hepatectomy.
This retrospective study included 920 consecutive elective patients undergoing liver resection from 2017 to 2023. Patient demographics, postoperative surgical outcomes, postoperative length of stay (LOS), and cost were compared between LLR and OLR before and after propensity score matching (PSM). A decision model was developed to assess the cost-effectiveness of LLR vs OLR.
After PSM, LLR was associated with significantly fewer postoperative transfusions for all hepatectomies (p < 0.001) and major hepatectomy (p = 0.001). LLR was associated with a shorter postoperative median LOS (p < 0.001), lower 30-day readmission (p = 0.022) and reoperation (p = 0.044) rate, and significantly reduced postoperative pneumonia (p = 0.038), unplanned intubation (p = 0.020), sepsis (p = 0.041), and major complication (p < 0.001) for all hepatectomies. This clinical superiority was complemented by a significant reduction in total cost for all (p < 0.001), minor (p = 0.001), and major (p < 0.001) hepatectomy. Cost-effectiveness analysis revealed that LLR was dominant over OLR, with a negative incremental cost-effectiveness ratio (-$2,120.72) and an increased net monetary benefit ($75,015.92) at the willingness-to-pay threshold of $25,000. The probability of LLR being cost-effective was 99.8% across various willingness-to-pay thresholds.
LLR is a safe and cost-effective alternative to OLR. Although LLR has higher initial procedural costs, these are offset by significant reduction in postoperative major complication, LOS, and total cost.
本研究比较了腹腔镜肝切除术(LLR)和开放肝切除术(OLR)在所有肝切除术中的临床和经济结果,包括小范围肝切除术和大范围肝切除术。
这项回顾性研究纳入了2017年至2023年连续接受肝切除术的920例择期患者。在倾向得分匹配(PSM)前后,比较了LLR组和OLR组患者的人口统计学特征、术后手术结果、术后住院时间(LOS)和费用。建立了一个决策模型来评估LLR与OLR的成本效益。
PSM后,LLR组在所有肝切除术(p < 0.001)和大范围肝切除术(p = 0.001)中的术后输血次数显著减少。LLR组术后中位LOS较短(p < 0.001),30天再入院率(p = 0.022)和再次手术率(p = 0.044)较低,并且在所有肝切除术中,术后肺炎(p = 0.038)、非计划插管(p = 0.020)、败血症(p = 0.041)和严重并发症(p < 0.001)显著减少。这种临床优势伴随着所有(p < 0.001)、小范围(p = 0.001)和大范围(p < 0.001)肝切除术总成本的显著降低。成本效益分析表明,LLR优于OLR,在支付意愿阈值为25000美元时,增量成本效益比为负(-$2120.72),净货币效益增加(75015.92美元)。在各种支付意愿阈值下,LLR具有成本效益的概率为99.8%。
LLR是OLR的一种安全且具有成本效益的替代方案。尽管LLR的初始手术成本较高,但术后严重并发症、LOS和总成本的显著降低抵消了这些成本。